Literature DB >> 23418854

Adenosine-binding motif mimicry and cellular effects of a thieno[2,3-d]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes.

Svend Kjær1, Mark Linch, Andrew Purkiss, Brenda Kostelecky, Phillip P Knowles, Carine Rosse, Philippe Riou, Christelle Soudy, Sarah Kaye, Bhavisha Patel, Erika Soriano, Judith Murray-Rust, Caroline Barton, Christian Dillon, Jon Roffey, Peter J Parker, Neil Q McDonald.   

Abstract

The aPKC [atypical PKC (protein kinase C)] isoforms ι and ζ play crucial roles in the formation and maintenance of cell polarity and represent attractive anti-oncogenic drug targets in Ras-dependent tumours. To date, few isoform-specific chemical biology tools are available to inhibit aPKC catalytic activity. In the present paper, we describe the identification and functional characterization of potent and selective thieno[2,3-d]pyrimidine-based chemical inhibitors of aPKCs. A crystal structure of human PKCι kinase domain bound to a representative compound, CRT0066854, reveals the basis for potent and selective chemical inhibition. Furthermore, CRT0066854 displaces a crucial Asn-Phe-Asp motif that is part of the adenosine-binding pocket and engages an acidic patch used by arginine-rich PKC substrates. We show that CRT0066854 inhibits the LLGL2 (lethal giant larvae 2) phosphorylation in cell lines and exhibits phenotypic effects in a range of cell-based assays. We conclude that this compound can be used as a chemical tool to modulate aPKC activity in vitro and in vivo and may guide the search for further aPKC-selective inhibitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23418854     DOI: 10.1042/BJ20121871

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

Review 1.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

2.  Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues.

Authors:  Jacek Kwiatkowski; Nithya Baburajendran; Anders Poulsen; Boping Liu; Doris Hui Ying Tee; Yun Xuan Wong; Zhi Ying Poh; Esther Hq Ong; Nurul Dinie; Joseph Cherian; Anna Elisabet Jansson; Jeffrey Hill; Thomas H Keller; Alvin W Hung
Journal:  ACS Med Chem Lett       Date:  2019-02-15       Impact factor: 4.345

3.  The chromosome 3q26 OncCassette: A multigenic driver of human cancer.

Authors:  Alan P Fields; Verline Justilien; Nicole R Murray
Journal:  Adv Biol Regul       Date:  2015-12-23

4.  Targeting oncogenic protein kinase Cι for treatment of mutant KRAS LADC.

Authors:  Alan P Fields; Syed A Ali; Verline Justilien; Nicole R Murray
Journal:  Small GTPases       Date:  2016-05-31

5.  Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.

Authors:  Amar N Mirza; Micah A Fry; Nicole M Urman; Scott X Atwood; Jon Roffey; Gregory R Ott; Bin Chen; Alex Lee; Alexander S Brown; Sumaira Z Aasi; Tyler Hollmig; Mark A Ator; Bruce D Dorsey; Bruce R Ruggeri; Craig A Zificsak; Marina Sirota; Jean Y Tang; Atul Butte; Ervin Epstein; Kavita Y Sarin; Anthony E Oro
Journal:  JCI Insight       Date:  2017-11-02

Review 6.  Targeting protein kinase C subtypes in pancreatic cancer.

Authors:  Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2015-01-20       Impact factor: 4.512

Review 7.  Dynamics and Membrane Interactions of Protein Kinase C.

Authors:  Tatyana I Igumenova
Journal:  Biochemistry       Date:  2015-08-05       Impact factor: 3.162

Review 8.  Protein kinase C pharmacology: refining the toolbox.

Authors:  Alyssa X Wu-Zhang; Alexandra C Newton
Journal:  Biochem J       Date:  2013-06-01       Impact factor: 3.857

9.  Structural Basis of Protein Kinase Cα Regulation by the C-Terminal Tail.

Authors:  Yuan Yang; Chang Shu; Pingwei Li; Tatyana I Igumenova
Journal:  Biophys J       Date:  2018-04-10       Impact factor: 4.033

10.  mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity.

Authors:  Xin Li; Tianyan Gao
Journal:  EMBO Rep       Date:  2013-12-27       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.